A major challenge in the war against cancer is to find ways to diagnose and treat the disease at an early stage when the cancer is still curable. This calls for sensitive and effective diagnostic tools that can sense the cellular state early in the process. Low cost tools will become especially important given that more than half of cancer cases and mortality occur in low- and middle-income countries, and these proportions are expected to increase by 2025.
Menu